Recent 2026 Milestones and Execution Progress::

  • Completed first human implant of the SINAPTIC Foot & Ankle Osteotomy Wedge System
  • Appointed Ryan Elmore as President to lead commercialization and strategic growth initiatives
  • Initiated preclinical animal studies evaluating silicon nitride in sutures, meshes, and wound care applications
  • Began transition toward AI-assisted 3D additive manufacturing, supported by new equipment and key technical hires
  • Advanced discussions regarding potential strategic partnerships across biomaterials and manufacturing platforms